Opiant Pharmaceuticals OverviewOpiant Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for OPNT.
Quarterly Other Income/Expense
-$278305.00
↓ 61265.93% YoY
As of Sep 30, 2022
Annual Other Income/Expense (TTM)
-$1.52M
↓ 9047.55% YoY
Trailing 12 months ending Sep 30, 2022